4.4 Review

Patterns of liver profile disturbance in patients with COVID-19

Related references

Note: Only part of the references are listed.
Article Oncology

Clinical characteristics and risk factors of COVID-19 patients with chronic hepatitis B: a multi-center retrospective cohort study

Jing Wang et al.

Summary: Patients with chronic hepatitis B (CHB) infected with COVID-19 are more likely to develop severe illness and have a higher risk of mortality. In addition to established liver impairment markers, novel risk factors such as elevated lactate dehydrogenase, D-dimer, and decreased albumin and albumin/globulin ratio were identified. These findings may aid in early clinical monitoring and identification of critical progression in COVID-19 patients.

FRONTIERS OF MEDICINE (2022)

Article Gastroenterology & Hepatology

Characteristics of Liver Function in Patients With SARS-CoV-2 and Chronic HBV Coinfection

Xiaojing Zou et al.

Summary: Liver injury in patients with SARS-CoV-2 and chronic HBV coinfection was associated with disease severity and poor prognosis. Monitoring of liver function and frequent evaluation should be emphasized during the treatment of COVID-19 in chronic HBV-infected patients.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

COVID-19 and liver injury: a meta-analysis

Karn Wijarnpreecha et al.

Summary: A meta-analysis study found that a quarter of COVID-19 patients had elevated liver enzymes, and it was associated with disease severity. The prevalence of elevated AST was significantly higher in severe cases, and the proportion of patients with co-existing chronic liver disease was also notable.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

Comparison of mortality risk in patients with cirrhosis and COVID-19 compared with patients with cirrhosis alone and COVID-19 alone: multicentre matched cohort

Jasmohan S. Bajaj et al.

Summary: Patients with cirrhosis and COVID-19 had higher mortality compared with patients with COVID-19 alone, but similar mortality compared with patients with cirrhosis alone. Charlson Comorbidity Index (CCI) was the only independent predictor of mortality in the entire matched cohort.
Review Gastroenterology & Hepatology

Elevated Liver Biochemistries in Hospitalized Chinese Patients With Severe COVID-19: Systematic Review and Meta-analysis

Alexander J. Kovalic et al.

Summary: This study found a higher prevalence of comorbidities such as coronary artery disease, cerebrovascular disease and chronic obstructive pulmonary disease in hospitalized Chinese patients with severe/critical COVID-19 infection. Abnormal liver chemistries, including elevated aspartate aminotransferase, total bilirubin, and decreased albumin levels, were also observed in severe cases.

HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients

Jordi Colmenero et al.

Summary: This study revealed that liver transplant patients have a higher risk of contracting COVID-19, but their mortality rate is lower than the general population. Baseline immunosuppression containing mycophenolate was identified as an independent predictor of severe COVID-19, especially at higher doses.

JOURNAL OF HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

Nonalcoholic fatty liver disease is associated with COVID-19 severity independently of metabolic syndrome: a retrospective case-control study

Mahmud Mahamid et al.

Summary: The study revealed that NAFLD patients were more likely to have severe COVID-19, regardless of gender and metabolic syndrome, especially in males. Other risk factors for severe COVID-19 included obesity, hypertension, and metabolic syndrome.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2021)

Article Immunology

Liver transplant recipients infected with SARS-CoV-2 in the early postoperative period: Lessons from a single center in the epicenter of the pandemic

Daniel Reis Waisberg et al.

Summary: This article reports a case series of five liver transplant recipients who developed nosocomial COVID-19 in the early postoperative period, with two patients experiencing significant respiratory distress and eventually dying, while the other three patients showed satisfactory clinical progress.

TRANSPLANT INFECTIOUS DISEASE (2021)

Review Pathology

Histopathological observations in COVID-19: a systematic review

Vishwajit Deshmukh et al.

Summary: This study reviewed and summarized the histopathological changes in different organs of COVID-19 patients, with findings including respiratory, cardiovascular, and nervous system involvement. It was observed that elderly patients and those with comorbidities are more susceptible to the effects of the virus.

JOURNAL OF CLINICAL PATHOLOGY (2021)

Letter Infectious Diseases

Acute hepatitis caused by asymptomatic COVID-19 infection

Marco Bongiovanni et al.

JOURNAL OF INFECTION (2021)

Article Virology

Low influenza vaccination coverage in subjects with liver cirrhosis. An alert waiting for winter season 2020-2021 during the COVID-19 pandemic

Tommaso Stroffolini et al.

Summary: This study evaluated flu vaccine coverage and associated variables in cirrhotic subjects, noting lower coverage in younger age groups, those with alcoholic etiology, foreign-born individuals, and those residing in the South/Sardinia region. Lack of information about the vaccine was reported more frequently by foreigners than natives. Efforts should be made to improve vaccine coverage in high-risk groups identified in the study.

JOURNAL OF MEDICAL VIROLOGY (2021)

Review Gastroenterology & Hepatology

Pathophysiological mechanisms of liver injury in COVID-19

Alexander D. Nardo et al.

Summary: This review discusses the potential mechanisms of hepatic tropism of SARS-CoV-2 and acute, possibly long-term liver injury in COVID-19.

LIVER INTERNATIONAL (2021)

Review Gastroenterology & Hepatology

COVID-19 and liver disease: mechanistic and clinical perspectives

Thomas Marjot et al.

Summary: This article provides insights into the mechanistic and clinical aspects of COVID-19 in the context of liver disease, discussing viral hepatotropism, differential expression of viral receptors on liver cell types, and liver histology features in COVID-19 patients. It also highlights the impact of COVID-19 on patients with pre-existing chronic liver disease and the potential strategies for managing these patients, including vaccination.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

Hepatic and gastrointestinal disturbances in Egyptian patients infected with coronavirus disease 2019: A multicentre cohort study

Hend Ibrahim Shousha et al.

Summary: Most Egyptian patients with COVID-19 did not develop severe liver injury. Independent factors affecting mortality included supplementary vitamin C intake, lung consolidation, ICU admission, and FIB-4 score.

WORLD JOURNAL OF GASTROENTEROLOGY (2021)

Review Gastroenterology & Hepatology

COVID-19 in normal, diseased and transplanted liver

Alessandro Signorello et al.

Summary: COVID-19 infection can cause multi-organ damage, including myocarditis, encephalitis, and acute kidney injury. The exact reasons for liver impairment during this infection are not completely understood, but it may involve various factors. Patients with normal liver function seem to only experience transient liver function test abnormalities, while those with reduced liver reserve are at higher risk for more severe complications.

WORLD JOURNAL OF GASTROENTEROLOGY (2021)

Review Biochemistry & Molecular Biology

Liver Disease: Induction, Progression, Immunological Mechanisms, and Therapeutic Interventions

Sarah Y. Neshat et al.

Summary: The liver has impressive regenerative potential but certain diseases can lead to liver fibrosis and eventually cirrhosis. This review discusses the complex immunological activities in liver diseases and the potential of mesenchymal stem cells in treatment. Preclinical studies show promising results in inhibiting host immunity, with ongoing clinical trials exploring cellular and non-cellular therapies for liver cirrhosis detection and treatment.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Medicine, General & Internal

Impact of COVID-19 on liver transplant recipients-A systematic review and meta-analysis

Anand Kulkarni et al.

Summary: This study analyzed the outcomes of liver transplant recipients with COVID-19 infection and found that there was no significant difference in mortality rates between liver transplant and non-liver transplant patients. The risk of developing severe COVID-19 infection in LT recipients was approximately 23%.

ECLINICALMEDICINE (2021)

Article Surgery

COVID-19 in Liver Transplant Recipients - Preliminary Experience of a Bulgarian Center

Ivelin Takorov et al.

Summary: The study aimed to investigate the impact of COVID-19 on liver transplant recipients and highlighted the importance of early diagnosis and hospitalization to prevent severe forms of the disease. The study found that comorbidities such as hypertension, diabetes, and obesity could increase the risk of severe COVID-19 in liver transplant recipients. It also emphasized the importance of adjusting immunosuppressive therapy dosages during treatment, especially for patients with severe disease.

CHIRURGIA (2021)

Review Gastroenterology & Hepatology

Cytokine Storm of COVID-19 and Its Impact on Patients with and without Chronic Liver Disease

Madhumita Premkumar et al.

Summary: The COVID-19 pandemic has exacerbated liver dysfunction in patients with existing liver diseases, and led to new onset organ failures in some cases. The virus can directly affect liver function and contribute to systemic issues in the body.

JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

Liver Chemistries in Patients With COVID-19 Who Were Discharged Alive or Died: A Meta-analysis

Qing-Qing Xing et al.

Summary: This meta-analysis study reveals the relationship between liver chemistries of COVID-19 patients and clinical outcomes, as well as different types of liver damage patterns. Patients who died generally have liver chemistries different from those who are discharged alive.

HEPATOLOGY COMMUNICATIONS (2021)

Article Surgery

Coronavirus disease 2019: Implications of emerging infections for transplantation

Marian G. Michaels et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2020)

Editorial Material Medicine, General & Internal

2019 Novel Coronavirus-Important Information for Clinicians

Carlos del Rio et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Medicine, General & Internal

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Chaolin Huang et al.

LANCET (2020)

Article Infectious Diseases

Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study

Heshui Shi et al.

LANCET INFECTIOUS DISEASES (2020)

Article Medicine, General & Internal

Clinical Characteristics of Coronavirus Disease 2019 in China

W. Guan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Review Gastroenterology & Hepatology

Review article: COVID-19 and liver disease-what we know on 1st May 2020

Isabel Garrido et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)

Editorial Material Toxicology

COVID-19 and drug-induced liver injury: a problem of plenty or a petty point?

Joost Boeckmans et al.

ARCHIVES OF TOXICOLOGY (2020)

Editorial Material Gastroenterology & Hepatology

Perioperative Presentation ofCOVID-19Disease in a Liver Transplant Recipient

Juanjuan Qin et al.

HEPATOLOGY (2020)

Article Gastroenterology & Hepatology

Acute Liver Injury in COVID-19: Prevalence and Association with Clinical Outcomes in a Large US Cohort

Meaghan M. Phipps et al.

HEPATOLOGY (2020)

Editorial Material Gastroenterology & Hepatology

Fast, faster, and fastest: science on the run during COVID-19 drama-do not forget the liver

S. K. Sarin

HEPATOLOGY INTERNATIONAL (2020)

Article Gastroenterology & Hepatology

Management of COVID-19 in patients after liver transplantation: Beijing working party for liver transplantation

Hongling Liu et al.

HEPATOLOGY INTERNATIONAL (2020)

Article Gastroenterology & Hepatology

COVID-19: Abnormal liver function tests

Qingxian Cai et al.

JOURNAL OF HEPATOLOGY (2020)

Article Hematology

The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome

Marco Ranucci et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

Letter Medicine, General & Internal

COVID-19: consider cytokine storm syndromes and immunosuppression

Puja Mehta et al.

LANCET (2020)

Review Gastroenterology & Hepatology

Liver injury during highly pathogenic human coronavirus infections

Ling Xu et al.

LIVER INTERNATIONAL (2020)

Review Gastroenterology & Hepatology

Hepatic and gastrointestinal involvement in coronavirus disease 2019 (COVID-19): What do we know till now?

Sherief Musa

ARAB JOURNAL OF GASTROENTEROLOGY (2020)

Editorial Material Gastroenterology & Hepatology

Liver injury in COVID-19: management and challenges

Chao Zhang et al.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)

Article Gastroenterology & Hepatology

Clinical Features of COVID-19-Related Liver Functional Abnormality

Zhenyu Fan et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)

Review Medicine, General & Internal

COVID-19 and non-alcoholic fatty liver disease: Two intersecting pandemics

Piero Portincasa et al.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2020)

Letter Gastroenterology & Hepatology

Prevention of SARS-CoV-2 infection in patients with decompensated cirrhosis

Yong Xiao et al.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)

Article Gastroenterology & Hepatology

Clinical characteristics in patients with SARS-CoV-2/HBV co-infection

Liping Chen et al.

JOURNAL OF VIRAL HEPATITIS (2020)

Article Medicine, Research & Experimental

A meta-analysis of the impact of COVID-19 on liver dysfunction

Zeng-hong Wu et al.

EUROPEAN JOURNAL OF MEDICAL RESEARCH (2020)

Review Gastroenterology & Hepatology

Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper

Tobias Boettler et al.

JHEP REPORTS (2020)

Review Medicine, General & Internal

Liver Injury in COVID-19 Infection: A Systematic Review

Atit Ghoda et al.

CUREUS JOURNAL OF MEDICAL SCIENCE (2020)

Review Gastroenterology & Hepatology

COVID-19 and Liver Dysfunction: Current Insights and Emergent Therapeutic Strategies

Gong Feng et al.

JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY (2020)

Article Gastroenterology & Hepatology

Liver stiffness by transient elastography accompanies illness severity in COVID-19

Maria Effenberger et al.

BMJ OPEN GASTROENTEROLOGY (2020)

Article Veterinary Sciences

The role of gut microbiota in intestinal and liver diseases

Tomas Hrncir et al.

LABORATORY ANIMALS (2019)

Review Gastroenterology & Hepatology

Liver - guardian, modifier and target of sepsis

Pavel Strnad et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)

Review Gastroenterology & Hepatology

Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance

Agustin Albillos et al.

JOURNAL OF HEPATOLOGY (2014)